Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|March 6, 2024
Application of pyroptosis score in the treatment and prognosis evaluation of gastric cancerLuyun Li, Aijun LiaoInternational Journal of Radiation Biology|March 21, 2022
<i>CASC7</i>: a LncRNA with potential clinical applicationTao Han, Aijun LiaoFrontiers in Immunology|February 17, 2025
The role of complement in tumor immune tolerance and drug resistance: a double-edged swordRonghui Yang, Di Fu, Aijun LiaoClinica Chimica Acta; International Journal of Clinical Chemistry|January 26, 2020
RASSF1A: A promising target for the diagnosis and treatment of cancerYuling Bin, Yong Ding, Weisheng Xiao, et al.Oncotargets and Therapy|April 28, 2021
Downregulation of Chemokine CCL20 Involved in Myeloma Cells Resistant to Elotuzumab and LenalidomideHuihan Wang, Hua Shi, Xiaowei He, et al.Molecular and Cellular Biochemistry|April 14, 2017
Hypomethylation agent decitabine restores drug sensitivity by depressing P-glycoprotein activity through MAPK signaling pathwayHuihan Wang, Xiaobin Wang, Aijun Liao, et al.Journal of Translational Medicine|June 30, 2022
Aberrant SPOP-CHAF1A ubiquitination axis triggers tumor autophagy that endows a therapeutical vulnerability in diffuse large B cell lymphomaWei Yan, Xue Shi, Huihan Wang, et al.International Journal of Molecular Medicine|July 25, 2020
miR‑144‑3p inhibits the proliferation, migration and angiogenesis of multiple myeloma cells by targeting myocyte enhancer factor 2AFei Tian, Huihan Wang, Huanxin Ma, et al.Scientific Reports|January 17, 2025
A systematic epidemiological trends analysis study in global burden of multiple myeloma and 29 years forecastQianru Hou, Xinyang Li, Huanxin Ma, et al.Oncotarget|January 7, 2016
RASSF1A inhibits gastric cancer cell proliferation by miR-711- mediated downregulation of CDK4 expressionAijun Liao, Gao Tan, Lin Chen, et al.Pageof 7